Extended-Release Dose Equivalence and Tablet Substitution
This dosing change cannot be approved without the specific medication name and the manufacturer’s FDA-labeled instructions for that extended-release formulation.
Extended-release tablets are not always dose-equivalent across different strengths when taking multiple tablets versus switching to a single higher-strength tablet.
Information Needed to Determine Safety
- Medication name and formulation (exact generic/brand name and whether it is extended-release).
- Prescribed dosing instructions from the current prescriber.
- The label’s guidance for switching between 150 mg extended-release and 300 mg extended-release strengths.
Clinical Guidance
The dosing should follow the prescribing information for the specific extended-release product and the transition plan documented by the prescriber or pharmacist.
If the label does not explicitly state that two 150 mg extended-release tablets can be used to achieve a 300 mg dose, the 300 mg tablet should be used instead of taking two 150 mg tablets.
Medication-Label Checks to Perform
- Maximum daily dose for that extended-release product.
- Tablet-conversion guidance between strengths (150 mg to 300 mg).
- Notes on crushing, splitting, or taking multiple tablets for dose changes.
Safe Next Step
A pharmacist should verify the equivalence and allowable administration method for the specific extended-release product before the dose is changed.